Eppendorf Centrifuge 5920 R: the new benchmark in capacity and performance
Also offers a powerful state-of-the-art refrigeration system with advanced temperature management.
Eppendorf’s new refrigerated Centrifuge 5920 R combines extraordinary high capacity with enhanced temperature management in a very compact and ergonomic product design.
Centrifuge 5920 R can accommodate up to 4 x standard 1 Liter Nalgene bottles, as well as up to 108 x 15 mL conical tubes, and 52 x 50 mL conical tubes, enabling researchers to spin large volumes at any one time, in applications such as bioprocessing or cell culture. Additionally, the universal rotor bucket design means researchers can spin both plates and tubes in the same bucket without the need to purchase separate plate buckets.
Eppendorf’s Centrifuge 5920 R also offers a powerful state-of-the-art refrigeration system with advanced temperature management, meaning users can be confident that their temperature-sensitive samples are safe. Dynamic compressor control technology and a FastTemp pro function also allows precise and automated pre-cooling based on a pre-programmable time and date.
Easy to use, the Centrifuge 5920 R features a multi-lingual menu with backlit display with 5 program keys enabling rapid access to routine programs, as well as an adjustable ECO shut-off function to save energy and increase compressor life. “With laboratories under increasing pressure to increase efficiencies and throughput we understand the challenges that researchers face in their work,” said Peter Schreiner, Global Product Manager Centrifugation at Eppendorf. “The very large capacity and precise temperature management offered by the Centrifuge 5920 R means researchers can be assured that not only are their samples safe, but that they are saving time, money and energy with this system.”
Related News
-
News Women in Pharma: Moving beyond discussions and into best practice at CPHI Milan
In this second CPHI Milan special of our monthly series, we cover the key takeaways from the Diversity & Wellbeing track held on October 10, 2024. -
News AstraZeneca invests in AI collaboration for cancer drug trials
The British-Swedish pharmaceutical giant is partnering with biotechnology firm Immunai Inc to increase the efficiency of some cancer drug trials. -
News Ozempic and Wegovy prices questioned as Novo Nordisk faces US Senate hearing
The CEO of Novo Nordisk was grilled during a US Senate committee hearing on September 24, 2024, in which the exorbitant prices of the Danish company’s blockbuster drugs Ozempic and Wegovy were called into question. -
News The BIOSECURE Act: implications for the pharma supply chain
On September 9, 2024, the US House of Representatives voted to pass the bill titled the BIOSECURE Act (the Act), which lists several Chinese companies in the pharmaceutical supply chain. The Act will prohibit American companies from contracting or doin... -
News On Track at CPHI Milan: Thermo Fisher Scientific Track Sponsor interview
With CPHI Milan just around the corner, we sat down with some of the sponsors for this year’s conference tracks to discuss the most pressing topics in pharma. -
News CPHI Milan Speaker Spotlight: Pharma Manufacturing and Localisation in Africa
In the run-up to CPHI Milan, we sit down with some of the experts and thought-leaders speaking at this year’s conferences. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Eli Lilly licenses rheumatoid arthritis manufacturing in Africa
American pharmaceutical company Eli Lilly has signed a partnership with Egyptian organisation Eva Pharma to localise manufacturing of rheumatoid arthritis treatments in Africa.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance